Bravo LA, LordMéndez JD, Medina MML, Béjar RY, Sánchez GS

Language: Spanish
References: 10
Page: 77-80
PDF size: 79.18 Kb.

ABSTRACT

The word apheresis is a term derived from the Greek «aphairesis», that means «to separate» or «to remove». Nowadays, apheresis procedures can be used with the aim of obtaining components for transfusion or with therapeutic aim (therapeutic apheresis). The American Society for Apheresis (ASFA) and the American Association of Blood Banks (AABB) have developed some guidelines of treatment for therapeutic apheresis; such guides are periodically modified according to medicine based on evidence. They have been classified in 4 categories, based on clinical response and the patient’s laboratory tests: category I, treatment accepted; category II, treatment with enough evidences of being effective in combination with other treatments; category III, controverted evidences of its effectiveness, and category IV, its effectiveness is not known and controlled studies are required. It is necessary to take into account the following when making an apheresis procedure: a) clinical history of the patient, b) letter of informed consent, c) vascular access, and d) evaluation of replacement liquids and consideration of adverse side effects to the access, the procedure and the anticoagulant.

REFERENCES

1. Abel J, Roundtree L, Turnes B. Plasma removal with return of corpuscles. J Pharmacol Exp Ther 1983; 5: 625-641.

2. Quintana GS. Recolección de Multicomponentes por aféresis. Gac Med Mex 2003; S5151-5154.

3. Petrides M. Aféresis terapéutica. En: Petrides M, Stack G, editores. Guía práctica de medicina transfusional. AABB Press, SETS Edición española. Sociedad Española de Transfusión Sanguínea; 2005. p. 329-350.

4. Owen GH, Brecher M. Management of therapeutic apheresis patient. En: Mc. Leod BC editor. Apheresis: Principles and practice. Bethesda, Maryland: AABB; 2003 .p. 223-245.

5. Eder FA, Kim H. Pediatric therapeutic apheresis. En Herman J and Manno C. Pediatric Transfusion Therapy. Bethesda, Maryland: AABB; 2002 .p. 471-508.

6. Smith JW, Weinstein R. Therapeutic apheresis: A summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003; 43: 820-822.

7. Consenso Mexicano de Guías para la Transfusión. Subcomité de Aféresis 2005. Puebla, Mexico: Pte. Publicación.

8. McLeod BC. Therapeutic apheresis: Use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange. Best Pract Res Clin Haematol 2006; 19: 157-167.

9. Rojas OE, Medina MM. Papel de la enfermera en aféresis. Rev Med IMSS 2005; 43: S153-156.

10. Wehrli R. Transfusion Therapy in Therapeutic Apheresis. En: Mintz PD, ed. Transfusion Therapy: Clinical Principles and Practices, 2nd ed. Bethesda, Maryland: AABB Press; 2005. p. 297-318.